Debut Funding: $80M Raised, Series B (2025)

Debut is a Biotech company based in San Diego. It has raised $80M in total funding. Latest round: Series B. Backed by L'Oréal's venture arm BOLD.

Debut funding overview

Debut is a Biotech company based in San Diego. Debut has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2025. The round record for Debut runs through 2025; nothing later has been disclosed. Investors on record include L'Oréal's venture arm BOLD.

Debut at a glance

Total raised
$80M
Latest round
Series B
Latest round date
January 2025
Industry
Biotech
Headquarters
San Diego
Notable investors
L'Oréal's venture arm BOLD

Frequently asked about Debut funding

How much has Debut raised?
Debut has raised $80M in total disclosed funding across the rounds on record.
Who has invested in Debut?
L'Oréal's venture arm BOLD are named among the investors backing Debut.
What was the latest Debut funding round?
The most recent disclosed round is a Series B, announced in January 2025.
Where is Debut based?
Debut is based in San Diego.
What sector does Debut operate in?
Debut is tracked under Biotech from San Diego, with $80M in disclosed funding.
When did Debut last raise?
The last disclosed Debut round closed in January 2025 at Series B.

Debut totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Diego below to benchmark round size and investor mix.

Debut founders (1)

Companies related to Debut (35)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026